Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings

BACKGROUND: Data on the modalities of disclosing genomic secondary findings (SFs) remain scarce. We explore cancer patients’ and the general public’s perspectives about disclosing genomic SFs and the modalities of such disclosure. METHODS: Sixty-one cancer patients (n = 29) and members of the public...

Descripción completa

Detalles Bibliográficos
Autores principales: Cléophat, Jude Emmanuel, Dorval, Michel, El Haffaf, Zaki, Chiquette, Jocelyne, Collins, Stephanie, Malo, Benjamin, Fradet, Vincent, Joly, Yann, Nabi, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236159/
https://www.ncbi.nlm.nih.gov/pubmed/34174888
http://dx.doi.org/10.1186/s12920-021-01016-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236159/
https://www.ncbi.nlm.nih.gov/pubmed/34174888
http://dx.doi.org/10.1186/s12920-021-01016-8

Ejemplares similares